Literature DB >> 11704983

Regulation of osteoclast formation and function.

L T Duong1, G A Rodan.   

Abstract

Mesh：

Year:  2001        PMID： 11704983     DOI： 10.1023/a:1010063225902

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  67 in total

Review 1.  Signaling through focal adhesion kinase.

Authors:  D D Schlaepfer; C R Hauck; D J Sieg
Journal:  Prog Biophys Mol Biol       Date:  1999       Impact factor: 3.667

2.  Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro.

Authors:  P T Lakkakorpi; H K Väänänen
Journal:  J Bone Miner Res       Date:  1991-08       Impact factor: 6.741

3.  Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity.

Authors:  K A Hruska; F Rolnick; M Huskey; U Alvarez; D Cheresh
Journal:  Ann N Y Acad Sci       Date:  1995-04-21       Impact factor: 5.691

4.  Tyrosine phosphorylation of p130Cas is involved in actin organization in osteoclasts.

Authors:  I Nakamura; E Jimi; L T Duong; T Sasaki; N Takahashi; G A Rodan; T Suda
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

5.  Bone sialoprotein coated on glass and plastic surfaces is recognized by different beta 3 integrins.

Authors:  M E Flores; D Heinegård; F P Reinholt; G Andersson
Journal:  Exp Cell Res       Date:  1996-08-25       Impact factor: 3.905

6.  A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.

Authors:  V W Engleman; G A Nickols; F P Ross; M A Horton; D W Griggs; S L Settle; P G Ruminski; S L Teitelbaum
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

7.  Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts.

Authors:  M A Horton; M L Taylor; T R Arnett; M H Helfrich
Journal:  Exp Cell Res       Date:  1991-08       Impact factor: 3.905

8.  Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein.

Authors:  J E Fisher; M P Caulfield; M Sato; H A Quartuccio; R J Gould; V M Garsky; G A Rodan; M Rosenblatt
Journal:  Endocrinology       Date:  1993-03       Impact factor: 4.736

9.  The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.

Authors:  B R Wong; R Josien; S Y Lee; M Vologodskaia; R M Steinman; Y Choi
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

10.  Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone.

Authors:  I Nakamura; M F Pilkington; P T Lakkakorpi; L Lipfert; S M Sims; S J Dixon; G A Rodan; L T Duong
Journal:  J Cell Sci       Date:  1999-11       Impact factor: 5.285
View more
  15 in total

1.  RANK ligand and the regulation of skeletal remodeling.

Authors:  Norman H Bell
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Epiphyseal abnormalities, trabecular bone loss and articular chondrocyte hypertrophy develop in the long bones of postnatal Ext1-deficient mice.

Authors:  Federica Sgariglia; Maria Elena Candela; Julianne Huegel; Olena Jacenko; Eiki Koyama; Yu Yamaguchi; Maurizio Pacifici; Motomi Enomoto-Iwamoto
Journal:  Bone       Date:  2013-08-17       Impact factor: 4.398

Review 3.  Osteoprotegerin as a potential therapy for osteoporosis.

Authors:  Neveen A T Hamdy
Journal:  Curr Osteoporos Rep       Date:  2005-12       Impact factor: 5.096

4.  Therapeutic inhibition of cathepsin K-reducing bone resorption while maintaining bone formation.

Authors:  Le T Duong
Journal:  Bonekey Rep       Date:  2012-05-02

5.  Primitive adult hematopoietic stem cells can function as osteoblast precursors.

Authors:  Elizabeth A Olmsted-Davis; Zbigniew Gugala; Fernando Camargo; Francis H Gannon; KathyJo Jackson; Kirsten Anderson Kienstra; H David Shine; Ronald W Lindsey; Karen K Hirschi; Margaret A Goodell; Malcolm K Brenner; Alan R Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

Review 6.  Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.

Authors:  F Ahmad; T Murata; K Shimizu; E Degerman; D Maurice; V Manganiello
Journal:  Oral Dis       Date:  2014-09-12       Impact factor: 3.511

Review 7.  Osteoprotegerin as a potential therapy for osteoporosis.

Authors:  Neveen A T Hamdy
Journal:  Curr Rheumatol Rep       Date:  2006-02       Impact factor: 4.592

8.  In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis.

Authors:  Peng Xiao; Yuan Chen; Hui Jiang; Yao-Zhong Liu; Feng Pan; Tie-Lin Yang; Zi-Hui Tang; Jennifer A Larsen; Joan M Lappe; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2008-05       Impact factor: 6.741

Review 9.  Pathophysiology of Osteonecrosis of the Jaws.

Authors:  Tara Aghaloo; Renna Hazboun; Sotirios Tetradis
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2015-09-26       Impact factor: 2.802

10.  Multifunctional role of osteopontin in directing intrafibrillar mineralization of collagen and activation of osteoclasts.

Authors:  Douglas E Rodriguez; Taili Thula-Mata; Edgardo J Toro; Ya-Wen Yeh; Carl Holt; L Shannon Holliday; Laurie B Gower
Journal:  Acta Biomater       Date:  2013-10-17       Impact factor: 8.947
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.